Bioinformatics firm Berg is combining multi-omics data from the Department of Defense's Center for Prostate Disease Research in search of biomarkers.
The funding will go toward completing the development of the company's point-of-care platform for distinguishing bacterial from viral infections.
The funding will advance work focused on the discovery of a genomic configuration that correlates to chemotherapy sensitivity.
It was a rough year for biotech stocks — the Nasdaq Biotech Index fell 22 percent even as the Dow gained 13 percent and the Nasdaq gained 8 percent.
The company's Keystone platform will have an iPhone-esque application platform for different tools used for forensic DNA data analysis.
The colon cancer test is now available through Tricare for 9.4 million active duty, reserve, and National Guard personnel, as well as veterans and their dependents.
Announced this month, the project brings together CPTAC, the VA, and DoD, and has as its initial goal the proteogenomic analysis of 8,000 lung cancer patients.
The Huntsville, Alabama-based genetic testing firm continues its relationship with the Combating Terrorism Technical Support Office.
IXpressGenes will study environmental DNA samples from extreme environments in order to find unique metabolic pathways that could yield new classes of antibiotics.
A GAO review finds no evidence of disparities in grant success rates by gender at agencies with sufficient data, but some agencies are not conducting required Title IX compliance reviews.
The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.
Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.
In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.
China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.